Abstract
The corneal copper content was measured by X-ray excitation spectrometry in two controls and in seven patients with Wilson's disease. Patients who were treated irregularly or not treated at all showed a high corneal copper content. Those who were adequately treated had low levels, comparable to the controls. In one case the corneal copper content declined by 45%, after a course of dimercaprol. The corneal copper measured showed no correlation with the slit-lamp appearance of the Kayser-Fleischer ring. It is suggested that non-invasive X-ray excitation spectrometry can provide a fast and reliable method for the early diagnosis of Wilson's disease and for the objective evaluation of the efficacy of the treatment of this disease.
Original language | English (US) |
---|---|
Pages (from-to) | 391-392 |
Number of pages | 2 |
Journal | The Lancet |
Volume | 307 |
Issue number | 7956 |
DOIs | |
State | Published - Feb 21 1976 |
Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)